BTK
Bruton agammaglobulinemia tyrosine kinase
BTK; Bruton agammaglobulinemia tyrosine kinase; AGMX1, IMD1; tyrosine-protein kinase BTK; ATK; PSCTK1; XLA; B-cell progenitor kinase; agammaglobulinaemia tyrosine kinase; tyrosine-protein kinase BTK isoform (lacking exon 14); dominant-negative kinase-defi;
B3GNT2
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2
B3GNT2; UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2; B3GNT1, UDP GlcNAc:betaGal beta 1,3 N acetylglucosaminyltransferase 1; B3GN T1; B3GN T2; B3GNT 2; BETA3GNT; B3GNT; Beta 1 3 galactosyltransferase 7; Beta3Gn T1; beta3Gn-T1; beta3Gn-T2; beta-1,3-Gn-T1; beta-1,3-Gn-T2; beta-1,3-N-acetylglucosaminyltransferase bGnT-1; beta-1,3-N-acetylglucosaminyltransferase bGnT-2; UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1; BGNT2; B3GNT1; BGnT-2; B3GN-T2; B3GNT-2;
DAD1
Defender Against Cell Death 1
OST2; DAD1; Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1; Oligosaccharyl transferase subunit DAD1; EC=2.4.1.119; Defender against cell death 1; AD-1; OTTHUMP00000164488; OTTHUMP00000239715; OTTHUMP00000239717; DAD-1; dolichyl-diphosphooligosaccharide--protein glycosyltransfe-rase subunit DAD1; EC 2.4.1.119; oligosaccharyltransferase 2 homolog;
B3GNT1
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1
B3GNT1; UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1; B3GNT6, UDP GlcNAc:betaGal beta 1,3 N acetylglucosaminyltransferase 6; N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase; B3GN T1; BETA3GNTI; iGAT; iGNT; iGnT; poly-N-acetyllactosamine extension enzyme; i-beta-1,3-N-acetylglucosaminyltransferase; beta-1,3-N-acetylglucosaminyltransferase bGnT-6; UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6; B3GNT6; B3GN-T1;
B3GNT3
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3
B3GNT3; UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3; TMEM3; B3GN T3; B3GNT 3; beta 1; 3 N acetylglucosaminyltransferase bGnT 3; beta3Gn T3; HP10328; putative type II membrane protein; transmembrane protein 3; B3GAL T8; B3GALT8; Beta 1,3 galactosyltransferase 8; Beta 3 Gal T8; Beta3Gal T8; Beta3GalT8; BGnT 3; BGnT3; Core 1 extending beta 1,3 N acetylglucosaminyltransferase; Core1 beta3GlcNAcT; UDP Gal:beta GlcNAc beta 1,3 galactosyltransferase 8; UDP GlcNAc:betaGal beta 1,3 N acetylglucosaminyltransferase 3; beta-3-Gx-T8; beta-1,3-Gn-T3; beta-1,3-GalTase 8; core1-beta3GlcNAcT; beta-1,3-N-acetylglucosaminyltransferase bGnT-3; UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 8; core 1 extending beta-1,3-N-acetylglucosaminyltransferase; UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 8; B3GN-T3; B3GNT-3; B3GAL-T8; beta3Gn-T3;
B3GALT6
UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6
B3GALT6; UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6; UDP Gal:betaGlcNAc beta 1,3 galactosyltransferase, polypeptide 6; beta-1,3-galactosyltransferase 6; beta 1; 3 galactosyltransferase 6; beta3GalT6; Beta 1 3 galactosyltransferase 6; Beta 3GalT6; GAG GalTII; Galactosyltransferase II; Galactosylxylosylprotein 3 beta galactosyltransferase; UDP Gal:betaGal beta 1 3 galactosyltransferase polypeptide 6; UDP Gal:betaGlcNAc beta 1 3 galactosyltransferase polypeptide 6; beta3Gal-T6; beta-1,3-GalTase 6; galactosylxylosylprotein 3-beta-galactosyltransferase; UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 6;
B3GNT6
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase)
B3GNT6; UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase); UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6; B3Gn T6; beta 1,3 Gn T6; beta 1,3 N acetylglucosaminyltransferase 6; beta 1,3 N acetylglucosaminyltransferase 6 protein; beta3Gn T6; core 3 synthase; UDP GlcNAc:betaGal beta 1,3 N acetylglucosaminyltransferase 6; BGnT-6; beta3Gn-T6; beta-1,3-Gn-T6; OTTHUMP00000229266; beta-1,3-N-acetylglucosaminyltransferase 6; beta-1,3-N-acetylglucosaminyltransferase protein; B3Gn-T6; IMAGE:4907098;
AGA
aspartylglucosaminidase
AGA; aspartylglucosaminidase; N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase; ASRG; glycosylasparaginase; AGU; Aspartylglucosylamine deaspartylase; Aspartylglycosaminuria; ASPG_HUMAN; GA; Glycosylasparaginase beta chain; N4 (N acetyl beta glucosaminyl) L asparagine amidase; N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase;
B3GNT4
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4
B3GNT4; UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4; B3GN T4; beta3Gn T4; BGnT-4; beta-1,3-Gn-T4; beta-1,3-N-acetylglucosaminyltransferase 4; beta-1,3-N-acetylglucosaminyltransferase bGn-T4; B3GN-T4; beta3Gn-T4;
B3GNT5
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5
B3GNT5; UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5; B3GN T5; beta3Gn T5; B3GN-T5; Beta 1,3 N acetyglucosaminyltransferase Lc3 synthase; Beta 1,3 N acetylglucosaminyltransferase 5; Beta 1,3-N acetylglucosaminyltransferase bGnT5; Beta-1,3-Gn-T5; Beta3Gn-T5; beta3GnT5; BGnT-5; EC 2.4.1.-; Lactotriaosylceramide synthase; Lc(3)Cer synthase; Lc3 synthase; UDP GlcNAc:betaGal beta 1,3 N acetylglucosaminyltransferase 5; OTTHUMP00000212932; beta-1,3-N-acetylglucosaminyltransferase 5; beta-1,3-N-acetylglucosaminyltransferase bGnT-5; beta 1,3 N-acetyglucosaminyltransferase Lc3 synthase;
IBTK
inhibitor of Bruton agammaglobulinemia tyrosine kinase
IBTK; inhibitor of Bruton agammaglobulinemia tyrosine kinase; Bruton agammaglobulinemia tyrosine kinase inhibitor , BTKI; inhibitor of Bruton tyrosine kinase; DKFZP564B116; BTK-binding protein; inhibitor of Brutons tyrosine kinase; inhibitor of Brutons ty;
B3GNTL1
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like 1
B3GNTL1;UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like 1;21727;ENSG00000175711;B3GNT8;17q25.3;MGC126253, MGC126256;UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1;UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1;BGnT-8;beta3Gn-T8;beta3GnTL1;beta-1,3-Gn-T8;BGnT-like protein 1;beta3Gn-T-like protein 1;beta-1,3-N-acetylglucosaminyltransferase 8;beta1,3-N-acetylglucosaminyltransferase-like protein 1;UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8;EC 2.4.1.-;
B3gnt7
B3GNT7 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 [ Homo sapiens ]
3-Gn-T7; 3-N-acetylglucosaminyltransferase 7; B3GN7_HUMAN; B3gnt7; Beta 1 3 N acetylglucosaminyltransferase 7; Beta-1; Beta3Gn T7; Beta3Gn-T7; beta3GnT7; BGnT 7; BGnT-7; UDP GlcNAc betaGal beta 1 3 N acetylglucosaminyltransferase 7; UDP-GlcNAc:betaGal beta-1;
Virus-specific Antibody—New Clue to against Norovirus Infection
The picture shows its X-ray crystallographic structure It could be said that norovirus was identified in 1972 and got its current namenorovirus in 2002 approved by ICTV . ...
Nature: New Finding on Gene MX2 Brings Clue to Against HIV
Our knowledge about Gene MX2 is poorly understood. Now researchers found a new potential of anti-HIV. Magazine Nature published the latest new finding on anti-HIV. This is the first time that researchers identified the impact of gene MX2 on H...
EU Regulatory: Giant Pharmaceuticals Are Fined Again for Disorganizing Market
On last Tuesday, EU regulators announced another pecuniary penalty event on pharmaceutical giant Johnson Johnson and Novartis because they tried to stop the selling launch of a cheaper painkiller biosimilar. They have to accept a fine of 16.3 million (i.e. $ 22 million); meanwhile European Commissi...
